Glaucoma is a progressive optic neuropathy that is the second leading cause of preventable
blindness worldwide, after cataract formation. A rise in the intraocular pressure (IOP) is …

Glaucoma is one of the leading causes of loss of vision. The problems associated with the
marketed formulations of anti-glaucoma drugs are low bioavailability, unwanted side effects …

Drug release kinetics in two compositions of methacrylate hydrogels were monitored as a
function of the hydrogel and drug molecular weight. Through modifying the molecular weight …

This study aims to evaluate the effect of different formulation variables (surfactant type and
HLB value) adopting full factorial design (5 1. 2 1) using coacervation phase technique on in …

Objective Our objective was to review, compare and gain insight into economic evaluations
in primary open-angle glaucoma (POAG) with a focus on existing decision analytic models …

Glaucoma, leading to progressive partial or complete blindness, is a matter of serious
concern worldwide. Although avoidable with right diagnosis and continuous treatment, a …

Drug-diffusion kinetics in 2-hydroxyethyl methacrylate hydrogels were studied as a function
of the crosslinking density and porosity. By varying the concentration of the crosslinker …

Despite its high risk of leading to permanent visual dysfunction, glaucoma remains
underdiagnosed in primary care settings. About 11% of glaucoma patients in Saudi Arabia …

Background Glaucoma is a neurodegenerative condition that affects the eye and is
associated with increased intraocular pressure. Intraocular pressure is the fluid pressure …

This article is the second in a series exploring the five major human senses. It examines
vision, exploring the anatomy and physiology of the eye, the accessory structures and the …